Sign in
Taking people in United StatesNo phase

Pounce Thrombectomy System for clots in peripheral arteries

Reviews Pounce device clot removal in peripheral arterial disease.

Key facts

Who runs it
SurModics, Inc.
Where
Austin, Baton Rouge, Cleveland, Greenville, Minneapolis, Munster, Nashville, Peoria, and Sioux Falls, United StatesSee the 9 sites
Trial code
Registry title
Pounce™ Thrombectomy System Retrospective Registry
Status
Recruiting
People taking part
500 people, planned
Started
18 Apr 2023
Planned end
31 Jul 2026
Type of study
Observational
Treatments tested
  • Pounce Thrombectomy System
Record updated
11 September 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who already had a procedure inside a blood vessel where the Pounce Thrombectomy System was tried. This device removes clots from arteries in the limbs. The study looks back at their records.

Age
18 Years and older
Sex
All
Disease stage
Peripheral arterial disease or acute limb ischemia (a sudden loss of blood flow to an arm or leg), with clots in the limb arteries.
Earlier treatment
People must have had a procedure inside the blood vessels where the Pounce Thrombectomy System was attempted.

Main reasons for not taking part

  • People under the age of 18 years cannot join.
  • People who did not give informed consent cannot join, unless a consent waiver is in place.

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Subject underwent an endovascular intervention where the Pounce Thrombectomy System was attempted
  • Subject is willing and able to provide informed consent prior to the collection of study data or a consent waiver is in place

Who cannot take part

  • Subject is under the age of 18 years

Where in United States

  • Ascension SetonAustin, United StatesContact: Clinical Program ManagerTaking people
  • Baton Rouge General Medical CenterBaton Rouge, United StatesContact: Clinical Program ManagerTaking people
  • Cleveland ClinicCleveland, United StatesContact: Clinical Program ManagerTaking people
  • Prisma Health-UpstateGreenville, United StatesContact: Clinical Program ManagerTaking people
  • Allina HealthMinneapolis, United StatesContact: Clinical Program ManagerNo longer taking part
  • Community HospitalMunster, United StatesContact: Clinical Program ManagerNo longer taking part
  • Vanderbilt University Medical CenterNashville, United StatesContact: Clinical Program ManagerTaking people
  • OSF St Francis Medical CenterPeoria, United StatesContact: Clinical Program ManagerTaking people
  • North Central HeartSioux Falls, United StatesContact: Clinical Program ManagerTaking people

About the trial

What the trial wants to find out

The PROWL registry is an open-label retrospective, multi-center, US study of the Surmodics™ Pounce™ Thrombectomy System for the non-surgical removal of emboli and thrombi in the peripheral arterial vasculature.

The group in the trial

  • Retrospective

    All subjects in whom the Pounce Thrombectomy System was attempted will be included.

    Treatment: Pounce Thrombectomy System

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Pounce™ Thrombectomy System Retrospective Registry
Plain-language title
Pounce Thrombectomy System for clots in peripheral arteriesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
11 September 2025